Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic

Benchmarks Nifty23,146.15148.81FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.8 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.64 % Invest NowEnter search text:

The Economic Times daily newspaper is available online now. Read Today's Paper Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic researchET BureauLast Updated: Oct 17, 2026, 06:01:00 PM ISTSynopsis

Shridevi Institute of Medical Sciences in Tumakuru has signed an MoU with Vaxonyx LLC for collaboration. This partnership aims to focus on AI-enabled bioinformatics and genomic research tailored for Indian populations. They will develop personalized cancer therapies by analyzing individual tumor profiles. The collaboration will also explore the creation of genomic datasets to improve genetic models. Moreover, they intend to develop DNA-based vaccine candidates for relevant public health issues.

Bengaluru: Shridevi Institute of Medical Sciences and Research Hospital, Tumakuru, has signed a Memorandum of Understanding (MoU) with US-based Vaxonyx LLC to collaborate on AI-enabled bioinformatics, genomic research, and therapeutic development, according to a statement issued by the institute.

The partnership seeks to combine Shridevi's clinical and academic capabilities with Vaxonyx's expertise in DNA therapeutics, vaccine research, immunology, and computational biology, the statement said.

Also Read: NITI Aayog explores policies to boost India's medical and dental device manufacturing industry

The collaboration will focus on generating therapeutic research data tailored to Indian populations and creating a translational pathway from laboratory research to patient care, with an initial emphasis on cancer therapeutics.

Under the collaboration, research will be undertaken in personalised cancer therapeutics by analysing the molecular profiles of individual tumours to identify potential targets for customised treatment strategies. The partners will also work on developing DNA-based vaccine candidates for specific diseases to address broader public health requirements.

Live Events

Also Read: From lifespan to healthspan: How Abu Dhabi and India can make prevention practical

A key focus area will be the creation of genomic datasets representing people of Indian ancestry through AI-enabled bioinformatics platforms. The initiative aims to improve the performance of genetic models across India's diverse population groups, including tribal communities.

The collaboration will further explore the development of human organoids, or miniature organ models grown from human cells, to support the evaluation of treatment approaches and drug candidates for various diseases.

Dr Kempaiah Rayavara, founder and chief executive officer of Vaxonyx LLC, said the Alabama-based company focuses on the unique biological characteristics of individual patients. "Computational analysis will help identify candidates for laboratory evaluation, with subsequent development guided by experimental evidence," he said.

Dr Shiva Kumar Rayavara, co-founder of Vaxonyx, said the company would lead the scientific strategy, molecular research planning, and development of computational tools under the partnership.

Dr M R Hulinaykar, founder chairman of the Shridevi Group of Educational Institutions, said the institution remains committed to advancing research in chronic, hereditary, and genetically mediated diseases. "The Shridevi Group will contribute clinical expertise, academic investigators, and research oversight across its medical, allied health sciences, pharmacy, nursing, and engineering institutions to promote scientific inquiry and develop solutions that benefit society," he said.

The MoU was signed in the presence of Dr Raman M Hulinaykar, director and trustee; M S Patil, director of human resources; trustees Dr Lavanya and Ambika M Hulinaykar; and Dr M L Harendra Kumar, principal of the medical college, among others.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News ongenomic researchMoU Vaxonyx Shridevi Institutepersonalised cancer therapeuticsDNA therapeuticsbiomedical research collaborationIndian genomic datasetsVaxonyx LLCShridevi Institute of Medical Sciencestherapeutic development

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

...moreless
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News ongenomic researchMoU Vaxonyx Shridevi Institutepersonalised cancer therapeuticsDNA therapeuticsbiomedical research collaborationIndian genomic datasetsVaxonyx LLCShridevi Institute of Medical Sciencestherapeutic development

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

...morelessContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories
& personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
in-depth stock reportsSubscribe NowET

Unlock Access to All Exclusives with ETPrime FREE TRIAL

15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

Trial offer expiring in00 : 05 : 00

I'd rather pay ₹2599 now

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Prime Account Detected!

It seems like you're already an ETPrime member with

Login using your ET Prime credentials to enjoy all member benefits

Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

Unlock ETPrime's Exclusive Stories Today!

Big Price Drop! Flat 40% Off

Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In now

Offer Exclusively For You

Save up to Rs. 700/-

ON ET PRIME MEMBERSHIP

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get Flat 40% Off

Then ₹ 1749 for 1 year

Avail Offer

Offer Exclusively For You

ET Prime at ₹ 49 for 1 month

Then ₹ 1749 for 1 year

Avail Offer

Special Offer

Get flat 40% off on ETPrime

Avail OfferAvail OfferClaim NowAlready a Member? Sign In now

Need Assistance?

Connect with an ETPrime expert for personalized support and guidance

+91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '

' + h3 + '

' + h4 + '

' + listing + '

'; $('#paidSCWidget').html(html); var callback = $('#paidSCWidget').attr('data-callback'); if(callback && window[callback]) { window[callback](); } customDimension.dimension72 += ' | Shown SYFT no Trial_With Missed Paywalled Articles Collection'; } else { _processNormal() } } }); } else { _processNormal(); } } catch (e) { _processNormal(); } }, function () { _processNormal(); }); //console.log('storyCollectionLoad', $); }

What’s Included with

ETPrime Membership

1Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with
in-depth insights that matter

• Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

  What Adani’s US indictment means for India Inc’s overseas fundraising

• Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

  Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?

• Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

  The problem with lab grown diamonds

• Why a falling rupee is a better option for the economy

  A list of top 20 momentum stocks that have delivered massive returns in one year

2Invest Wisely With Smart Market Tools & Investment Ideas

Alpha Trade

Get daily trade ideas from SEBI-registered research analysts.

Investment Ideas

Grow your wealth with stock ideas & sectoral trends.

Stock Reports Plus

All-in-one stock research with Stock Score, peer comparison & key signals.

BigBull Portfolio

Get to know where the market bulls are investing to identify the right stocks.

Stock Analyzer

Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.

Market Mood

Analyze the market sentiments & identify the trend reversal for strategic decisions.

Stock Talk Live at 9 AM Daily

Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.

3Stay informed anytime, anywhere with ET ePaper

ePaper - Print View

Read the PDF version of ET newspaper. Download & access it offline anytime.

ePaper - Digital View

Read your daily newspaper in Digital View & get it delivered to your inbox everyday.

Wealth Edition

Manage your money efficiently with this weekly money management guide.

TOI ePaper

Read the PDF version of TOI newspaper. Download & access it offline anytime.

Deep Explainers

Explore the In-depth explanation of complex topics for everyday life decisions.

Health+ Stories

Get fitter with daily health insights committed to your well-being.

Personal Finance+ Stories

Manage your wealth better with in-depth insights & updates on finance.

5Enjoy Complimentary Subscriptions From Top Brands

Stream new documentaries from all across the world every day.

Stories you might be interested in